These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 32522713)

  • 21. Induction or neoadjuvant therapy in resectable non-small cell lung cancer.
    Langer CJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):34-9. PubMed ID: 10566609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC].
    Wang H; Han Y
    Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):822-832. PubMed ID: 38061884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant therapy in non-small cell lung cancer.
    Grant C; Hagopian G; Nagasaka M
    Crit Rev Oncol Hematol; 2023 Oct; 190():104080. PubMed ID: 37532102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer: A Systematic Review.
    Zhao Z; Gao Y; Xue Q; Gao S; He J
    Target Oncol; 2021 Jul; 16(4):425-434. PubMed ID: 33983556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.
    Sun X; Liu W; Sun L; Mo H; Feng Y; Wu X; Li C; Chen C; Li J; Xin Y; Zhang Z; Wang C; Zhang B; Yue D
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 37011953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?
    Ahern E; Solomon BJ; Hui R; Pavlakis N; O'Byrne K; Hughes BGM
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of surgery in a novel multimodal therapeutic approach to complete cure of advanced lung cancer: current and future perspectives.
    Yamane M; Toyooka S
    Surg Today; 2022 Jan; 52(1):1-11. PubMed ID: 33738585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy for non-small cell lung cancer.
    Pinder-Schenck M; Bepler G
    Minerva Chir; 2009 Dec; 64(6):611-28. PubMed ID: 20029358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer.
    Shen J; Gu L; Qi Y; Yao Y; Lu S; Chen Z
    Front Immunol; 2023; 14():1268251. PubMed ID: 37818382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress on Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer].
    Qi C; Tian P; Li W
    Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):138-146. PubMed ID: 38453446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
    Kocher F; Pircher A; Mohn-Staudner A; Romeder F; Duller W; Steinmaurer M; Eckmayr J; Schmid T; Hilbe W; Fiegl M; Greil R
    Lung Cancer; 2014 Sep; 85(3):395-400. PubMed ID: 25043642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer.
    Conroy MR; Dennehy C; Forde PM
    Lung Cancer; 2023 Sep; 183():107314. PubMed ID: 37541935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy.
    John AO; Ramnath N
    Oncologist; 2023 Sep; 28(9):752-764. PubMed ID: 37338126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated management of stage III in nonsmall cell lung cancer: where do perioperative chemotherapy and immunotherapy fit?
    Collazo-Lorduy A; Blanco M; Calvo V; Provencio M
    Curr Opin Pulm Med; 2024 Jul; 30(4):346-351. PubMed ID: 38712693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone.
    Tang WF; Ye HY; Tang X; Su JW; Xu KM; Zhong WZ; Liang Y
    Front Oncol; 2023; 13():1063183. PubMed ID: 36776323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung Cancer.
    Chaft JE; Dziadziuszko R; Haddock Lobo Goulart B
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432500. PubMed ID: 38788177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant and neo-adjuvant immunotherapy in resectable non-small cell lung cancer (NSCLC): Current status and perspectives.
    Xu Z; Zou Z; Hao X; Xing P; Li J
    Cancer Innov; 2023 Feb; 2(1):65-78. PubMed ID: 38090369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical perspective in neoadjuvant chemoimmunotherapy for stage II-III non-small cell lung cancer.
    Hong T; Sun T; Zhang M; Liu X; Yuan Y; Dolo PR; Chen B; Zhang H
    Thorac Cancer; 2021 Oct; 12(20):2796-2802. PubMed ID: 34463034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platinum versus immunotherapy for early resectable non-small cell lung cancer: A protocol for systematic review and meta analysis.
    Tong Z; Luo F; Yang X; Kang M; Lin J
    Medicine (Baltimore); 2020 Oct; 99(43):e22349. PubMed ID: 33120735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review.
    Gatteschi L; Iannopollo M; Gonfiotti A
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.